Fosun Pharma (02196.HK) completed the issuance of the first phase of medium-term notes (Innovation Notes) for the year 2025.

Zhijong Financial News APP, Fosun Pharma (02196.HK) announced that the company recently completed the issuance of the first tranche of medium-term notes (innovative notes) for the year 2025 within the registered quota under the notification letter.